In Brief: Organic Guidance; NAD Review; FTC Enforcement; FDA Warning
This article was originally published in The Tan Sheet
Executive Summary
USDA organic guidance; NAD challenges Akeso’s “doctor recommended” claims; new name for NCCAM proposed; FTC finalizes decree with GeneLink; Fortune Hi-Tech Marketing resolves pyramid allegations; CDJ supplements are unapproved new drugs; more news In Brief.
You may also be interested in...
In Brief: laxatives warning, FTC settlement, ChromaDex inks 5LINX deal
Sodium phosphate laxatives linked to SAERs; FTC scrutinizes personalized supplement claims; NAD refers Xlear LLC to FTC; ChromaDex inks marketing deal with 5LINX; CVS launches vitamin sales, info hub on its website; Star Scientific shareholder suit proceeds.
Fortune Hi-Tech Complaint Could Intensify Scrutiny Of Multilevel Marketers
FTC worked with state authorities in an investigation of multilevel marketer Fortune Hi-Tech that led to a court order shutting down the firm. Meanwhile, nutritional and cosmetic product firm Nu Skin offers a defense against criticism of the multilevel business model after investors target Herbalife.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.